FindTrial
Sign In

A randomized, controlled, multicenter clinical trial comparing the efficacy of Peginterferon alfa-2a and ribavirin and metformin versus Peginterferon alfa-2a and ribavirin for the treatment of naïve patients with chronic hepatitis C (CHC) and insulin resistance. - ND

A randomized, controlled, multicenter clinical trial comparing the efficacy of Peginterferon alfa-2a and ribavirin and metformin versus Peginterferon alfa-2a and ribavirin for the treatment of naïve patients with chronic hepatitis C (CHC) and insulin resistance. - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-003853-29-IT
Enrollment
Unknown
Registered
2007-11-07
Start date
2005-12-09
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHRONIC ACTIVE HEPATITIS C ASSOCIATED WITH INSULIN RESISTANCE MedDRA version: 6.1 Level: PT Classification code 10019744

Interventions

Trade Name: GLUCOPHAGE*30CPR RIV 500MG Pharmaceutical Form: Tablet INN or Proposed INN: Metformin CAS Number: 1115-70-4 Concentration unit: mg milligram(s) Concentration type: equal Concentration numb

Sponsors

AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026